Viewray (NASDAQ:VRAY) was downgraded by equities research analysts at BidaskClub from a “hold” rating to a “sell” rating in a report released on Wednesday.

Other research analysts also recently issued reports about the company. Northland Securities reiterated a “buy” rating and set a $10.00 target price on shares of Viewray in a research note on Friday, November 17th. Mizuho restated a “buy” rating and issued a $12.00 price target on shares of Viewray in a research note on Monday, November 13th. B. Riley initiated coverage on Viewray in a research note on Thursday, February 8th. They issued a “buy” rating and a $13.50 price target for the company. Cantor Fitzgerald set a $13.00 price target on Viewray and gave the company a “buy” rating in a research note on Monday, January 8th. Finally, ValuEngine downgraded Viewray from a “hold” rating to a “sell” rating in a research note on Friday, December 1st. Two investment analysts have rated the stock with a sell rating and six have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $11.58.

Viewray (NASDAQ VRAY) opened at $7.75 on Wednesday. The company has a debt-to-equity ratio of -1.67, a quick ratio of 1.20 and a current ratio of 1.59. Viewray has a one year low of $4.40 and a one year high of $10.64. The company has a market capitalization of $524.81, a P/E ratio of -7.11 and a beta of 14.36.

Viewray (NASDAQ:VRAY) last issued its earnings results on Monday, November 13th. The company reported ($0.19) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.12) by ($0.07). The firm had revenue of $12.20 million during the quarter, compared to the consensus estimate of $18.63 million. The firm’s quarterly revenue was up 2950.0% compared to the same quarter last year. research analysts anticipate that Viewray will post -1.05 earnings per share for the current fiscal year.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in VRAY. Schwab Charles Investment Management Inc. bought a new stake in Viewray in the 2nd quarter valued at $323,000. Bank of New York Mellon Corp boosted its stake in Viewray by 146.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 109,348 shares of the company’s stock valued at $707,000 after purchasing an additional 64,976 shares during the period. Alliancebernstein L.P. bought a new stake in Viewray in the 2nd quarter valued at $248,000. Teachers Advisors LLC raised its holdings in Viewray by 668.8% in the 2nd quarter. Teachers Advisors LLC now owns 53,782 shares of the company’s stock valued at $348,000 after acquiring an additional 46,786 shares in the last quarter. Finally, TIAA CREF Investment Management LLC raised its holdings in Viewray by 2,447.3% in the 2nd quarter. TIAA CREF Investment Management LLC now owns 286,365 shares of the company’s stock valued at $1,853,000 after acquiring an additional 275,123 shares in the last quarter. Institutional investors and hedge funds own 50.61% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This story was published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this story on another site, it was copied illegally and republished in violation of international trademark and copyright law. The original version of this story can be viewed at https://theolympiareport.com/2018/02/14/viewray-vray-downgraded-by-bidaskclub.html.

Viewray Company Profile

ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.

Analyst Recommendations for Viewray (NASDAQ:VRAY)

Receive News & Ratings for Viewray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viewray and related companies with MarketBeat.com's FREE daily email newsletter.